IMO this is a very good announcement. Im sure all shareholders (and the market) was wondering how the next lot of funding was going to be organised.
By going with Lang this IMO is a strong set of hands - less likely for the discounted shares to be dumped on the market for a ST profit.
Not to mention - from the trial perspective - it seems like its full steam ahead, with results due early next year.
It wouldnt surprise me if the SP bottom has now been declared.
Onwards and Upwards
Ann: Neuren expands Phase 2 Rett syndrome pediatric trial-NEU.AX, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.21 |
Change
0.580(3.49%) |
Mkt cap ! $2.167B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $4.123M | 242.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 87 | $17.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.22 | 6 | 3 |
View Market Depth
| Last trade - 13.11pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |